The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Muscle Wasting Disorders Market Grow Between 2026 And 2030?
The muscle wasting disorders market size has seen rapid growth in recent years. It is anticipated to increase from $17.49 billion in 2025 to $19.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.2%. This historic growth can be attributed to the prevalence of muscular dystrophy and ALS, the expanded use of physical therapy, an increase in nutritional supplement usage, the early adoption of anti-inflammatory treatments, and the development of hospital-based rehabilitation services.
The muscle wasting disorders market size is anticipated to undergo significant expansion in the coming years, projected to reach $33.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This growth during the forecast period is driven by advancements in gene therapy technologies, increasing investment in regenerative medicine, the expansion of specialized rehabilitation centers, a growing demand for personalized treatment plans, and a heightened focus on nutritional interventions. Key trends for the forecast period include the increasing adoption of gene therapy for muscle regeneration, a rising utilization of nutritional and protein supplementation, an increased demand for physical rehabilitation programs, the expansion of targeted therapies for muscular dystrophy, and a growing application of hormonal and anti-inflammatory medications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp
Which Factors Are Influencing The Growth Of The Muscle Wasting Disorders Market?
The muscle wasting disorders market is projected to experience growth due to the increasing adoption of sedentary lifestyles. A sedentary lifestyle describes a way of living where an individual is physically inactive, engaging in minimal or no physical movement or exercise. Such behavior can negatively impact muscle function, resulting in a decline in muscle strength and endurance, contributing to muscle wasting disorders, and making it more challenging for individuals to preserve their muscle mass and function. For example, in March 2025, NHS England, a UK-based executive non-departmental public body, reported that over one-quarter of adults were considered inactive, while in 2023, nearly one-third of children and young people (30.2 percent) engaged in less than 30 minutes of daily physical activity. Consequently, the rising adherence to a sedentary lifestyle is fueling the expansion of the muscle wasting disorders market.
What Are The Key Segment Divisions In The Muscle Wasting Disorders Market Segment Structure?
The muscle wasting disorders market covered in this report is segmented –
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices
Which Trends Are Influencing Demand In The Muscle Wasting Disorders Market?
Major companies operating in the muscle wasting disorders market are developing innovative products, such as novel gene therapy, to better serve patients with muscle wasting disorders. Novel gene therapy refers to a medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or altering the biological properties of living cells. For instance, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, introduced Elevidys, which is the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy designed to deliver into the body a gene that leads to a shortened protein that contains selected domains of the dystrophin protein of normal muscle cells. The product is administered as a single intravenous infusion.
Which Organizations Are Engaged In The Muscle Wasting Disorders Market?
Major companies operating in the muscle wasting disorders market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics, Biophytis SA, TNF Pharmaceuticals Inc., Rejuvenate Biomed, Edgewise Therapeutics
Get The Full Muscle Wasting Disorders Market Report:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report
Which Region Is The Top Contributor To The Muscle Wasting Disorders Market By Share?
North America was the largest region in the muscle wasting disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Muscle Wasting Disorders Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report
Browse Through More Reports Similar to the Global Muscle Wasting Disorders Market 2026, By The Business Research Company
Spasmodic Dysphonia Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/spasmodic-dysphonia-treatment-global-market-report
Muscle Pain Treatment Market Report
https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report
Muscle Spasticity Market Report
https://www.thebusinessresearchcompany.com/report/muscle-spasticity-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model